戎美股份 reported revenue of ¥0.23B for the period ended 2026-06-30, -24.0% year on year. Net income was ¥0.02B, a 10.5% net margin on a 46.6% gross margin. The largest revenue line is 上衣 at 37% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.23B | -24.0% |
| Gross profit | ¥0.11B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.02B | -34.9% |
| Gross margin | 46.6% | Net margin 10.5% |
| Revenue Q/Q | +1.2% | — |
| Segment | Revenue | Share |
|---|---|---|
| 上衣 | ¥0.08B | 36.5% |
| 外套 | ¥0.04B | 18.9% |
| 裤类 | ¥0.04B | 16.8% |
| 裙类 | ¥0.03B | 11.1% |
| 其他 | ¥0.02B | 6.7% |
| 珠宝 | ¥0.01B | 5.1% |
| 皮草 | ¥0.01B | 3.5% |
| 其他(补充) | ¥0.00B | 1.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.12B | 53.4% |
| R&D | ¥0.01B | 3.6% |
| SG&A | ¥0.06B | 26.8% |
| Tax & other | ¥0.01B | 2.4% |
| Item | Amount |
|---|---|
| Total assets | ¥2.47B |
| Total liabilities | ¥0.05B |
| Shareholders' equity | ¥2.42B |
| Equity / assets | 98.0% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 139% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
拓新药业 ・ 华润材料 ・ 深城交 ・ 争光股份 ・ 华兰股份 ・ 广立微 ・ 百诚医药 ・ 天益医疗 ・ 金埔园林 ・ 雅创电子 ・ 风光股份 ・ 明月镜片
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies